Vanya Slavova-Boneva
United Kingdom (UK)
Biographical Info
MPharmSci, PGDipGPP, IPresc, MRCPharm, AFHEA, mBOPA Vanya Slavova-Boneva is a Specialist Senior Adult Oncology Programme (SAOP) Pharmacist at The Royal Marsden NHS Foundation Trust and Senior Lecturer in Cancer Care at The Royal Marsden School, UK. She leads clinical pharmacy services within SAOP, working as part of a multidisciplinary team to deliver personalised and holistic care for patients aged ≥65 years with cancer. She is also a Non-Medical Prescriber specialising in breast cancer, providing advanced clinical assessment and prescribing as part of the multidisciplinary breast oncology service. She specialised in oncology in 2014, completing a Postgraduate Diploma in General Pharmacy Practice (UCL) and qualifying as an Independent Prescriber in 2019. In 2022, she became the first pharmacist to successfully complete the SIOG Advanced Course in Geriatric Oncology. She recently completed a Pre-Doctoral Fellowship funded by The Royal Marsden Cancer Charity, focusing on developing innovative digital and non-digital approaches to improve medication safety, adherence and patient education for older adults with cancer, enhancing their quality of life and treatment experience. Vanya has extensive experience across haemato-oncology and solid tumours, with research and clinical interests in geriatric oncology, medicine optimisation, polypharmacy and digital health. She is the Principal Investigator of the DIGIMED study, a multi-centre research programme exploring medicine optimisation through digital and non-digital platforms for older adults with cancer, with the aim of improving medication safety, adherence, patient experience and equitable access to digital healthcare. She has published in the Journal of Geriatric Oncology and the International Journal of Clinical Pharmacy, and contributes to international guidelines, book chapters and best practice papers. She is a regular speaker at national and international conferences, including BOPA, SIOG, Clinical Pharmacy Congress (CPC) and the UK Oncology Forum (UKOF). She serves as Chair of the BOPA Geriatric Oncology Advisory Group, committee member of the BOPA Research, Equality, Diversity and Inclusion (EDI), and Immunotherapy groups, member of the Royal Marsden Research and Audit Forum, and Governance Committee member of the SIOG Nursing, Allied Health and Scientists Interest Group. She also collaborates internationally through SIOG, CARG, ISOPP and the UK Immuno-Oncology Clinical Network. Her leadership and research contributions were recognised with the HSJ Patient Safety Award (2024) as part of the Royal Marsden SAOP team for improving care for older people.